SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-22-010258
Filing Date
2022-10-04
Accepted
2022-10-04 06:15:21
Documents
12
Period of Report
2022-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_100122.htm   iXBRL 8-K 22597
  Complete submission text file 0001387131-22-010258.txt   194654

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20221001.xsd EX-101.SCH 3266
3 XBRL LABEL FILE admp-20221001_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE admp-20221001_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_100122_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 221289688
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences